Literature DB >> 15044486

Characterization of human UDP-glucose dehydrogenase. CYS-276 is required for the second of two successive oxidations.

Brandi J Sommer1, Joseph J Barycki, Melanie A Simpson.   

Abstract

UDP-glucose dehydrogenase (UGDH) catalyzes two oxidations of UDP-glucose to yield UDP-glucuronic acid. Pathological overproduction of extracellular matrix components may be linked to the availability of UDP-glucuronic acid; therefore UGDH is an intriguing therapeutic target. Specific inhibition of human UGDH requires detailed knowledge of its catalytic mechanism, which has not been characterized. In this report, we have cloned, expressed, and affinity-purified the human enzyme and determined its steady state kinetic parameters. The human enzyme is active as a hexamer with values for Km and Vmax that agree well with those reported for a bovine homolog. We used crystal coordinates for Streptococcus pyogenes UGDH in complex with NAD+ cofactor and UDP-glucose substrate to generate a model of the enzyme active site. Based on this model, we selected Cys-276 and Lys-279 as likely catalytic residues and converted them to serine and alanine, respectively. Enzymatic activity of C276S and K279A point mutants was not measurable under normal assay conditions. Rate constants measured over several hours demonstrated that K279A continued to turn over, although 250-fold more slowly than wild type enzyme. C276S, however, performed only a single round of oxidation, indicating that it is essential for the second oxidation. This result is consistent with the postulated role of Cys-276 as a catalytic residue and supports its position in the reaction mechanism for the human enzyme. Lys-279 is likely to have a role in positioning active site residues and in maintaining the hexameric quaternary structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044486     DOI: 10.1074/jbc.M401928200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Cloning, expression, purification, crystallization and preliminary crystallographic studies of BceC, a UDP-glucose dehydrogenase from Burkholderia cepacia IST408.

Authors:  Joana Rocha; Alma O Popescu; Isabel Sá-Correia; Arsénio M Fialho; Carlos Frazão
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-02-24

2.  UDP-glucose dehydrogenase polymorphisms from patients with congenital heart valve defects disrupt enzyme stability and quaternary assembly.

Authors:  Annastasia S Hyde; Erin L Farmer; Katherine E Easley; Kristy van Lammeren; Vincent M Christoffels; Joseph J Barycki; Jeroen Bakkers; Melanie A Simpson
Journal:  J Biol Chem       Date:  2012-07-18       Impact factor: 5.157

3.  Divergent Sp1 protein levels may underlie differential expression of UDP-glucose dehydrogenase by fibroblasts: role in susceptibility to orbital Graves disease.

Authors:  Shanli Tsui; Roshini Fernando; Beiling Chen; Terry J Smith
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

4.  Structure of Burkholderia cepacia UDP-glucose dehydrogenase (UGD) BceC and role of Tyr10 in final hydrolysis of UGD thioester intermediate.

Authors:  Joana Rocha; Alma O Popescu; Patrícia Borges; Dalila Mil-Homens; Leonilde M Moreira; Isabel Sá-Correia; Arsénio M Fialho; Carlos Frazão
Journal:  J Bacteriol       Date:  2011-05-20       Impact factor: 3.490

5.  The UDP-glucose dehydrogenase of Escherichia coli K-12 displays substrate inhibition by NAD that is relieved by nucleotide triphosphates.

Authors:  Iain L Mainprize; Jordan D Bean; Catrien Bouwman; Matthew S Kimber; Chris Whitfield
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

6.  New methods to assess 6-thiopurine toxicity and expanding its therapeutic application to pancreatic cancer via small molecule potentiators.

Authors:  Chamitha Weeramange; Ashabha Lansakara; Johnathan Dallman; Thi Nguyen; Wasundara Hulangamuwa; Ryan J Rafferty
Journal:  Medchemcomm       Date:  2019-03-18       Impact factor: 3.597

7.  Glycosaminoglycan-dependent restriction of FGF diffusion is necessary for lacrimal gland development.

Authors:  Xiuxia Qu; Yi Pan; Christian Carbe; Andrea Powers; Kay Grobe; Xin Zhang
Journal:  Development       Date:  2012-06-28       Impact factor: 6.868

8.  UDP-glucose dehydrogenase activity and optimal downstream cellular function require dynamic reorganization at the dimer-dimer subunit interfaces.

Authors:  Annastasia S Hyde; Ashley M Thelen; Joseph J Barycki; Melanie A Simpson
Journal:  J Biol Chem       Date:  2013-10-21       Impact factor: 5.157

9.  Structural Characterization of CalS8, a TDP-α-D-Glucose Dehydrogenase Involved in Calicheamicin Aminodideoxypentose Biosynthesis.

Authors:  Shanteri Singh; Karolina Michalska; Lance Bigelow; Michael Endres; Madan K Kharel; Gyorgy Babnigg; Ragothaman M Yennamalli; Craig A Bingman; Andrzej Joachimiak; Jon S Thorson; George N Phillips
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

Review 10.  Integration of Sugar Metabolism and Proteoglycan Synthesis by UDP-glucose Dehydrogenase.

Authors:  Brenna M Zimmer; Joseph J Barycki; Melanie A Simpson
Journal:  J Histochem Cytochem       Date:  2020-08-04       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.